Scarica l'app Stockscreener
1.20
1.69%
0.02
Pre-mercato:
1.17
-0.03
-2.50%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BNGO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.18
Aprire:
$1.18
Volume 24 ore:
583.50K
Relative Volume:
1.84
Capitalizzazione di mercato:
$12.21M
Reddito:
$28.51M
Utile/perdita netta:
$-26.40M
Rapporto P/E:
-0.2192
EPS:
-5.4756
Flusso di cassa netto:
$-16.35M
1 W Prestazione:
+7.14%
1M Prestazione:
+4.35%
6M Prestazione:
-29.82%
1 anno Prestazione:
-63.64%
Intervallo 1D:
$1.11
$1.205
Intervallo di 1 settimana:
$1.0921
$1.47
Portata 52W:
$1.06
$5.50
Bionano Genomics Inc Stock (BNGO) Company Profile
Nome
Bionano Genomics Inc
Settore
Industria
Telefono
(858) 888-7600
Indirizzo
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.20 | 12.21M | 28.51M | -26.40M | -16.35M | -5.4756 |
ISRG
Intuitive Surgical Inc
|
469.98 | 166.92B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.27 | 45.02B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.26 | 36.68B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.67 | 34.63B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.31 | 32.97B | 5.40B | 1.49B | 1.78B | 10.12 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2024-09-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-12 | Ripresa | BTIG Research | Buy |
| 2022-07-18 | Ripresa | Oppenheimer | Outperform |
| 2021-06-16 | Iniziato | BTIG Research | Buy |
| 2020-09-24 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-04-08 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Bionano Genomics Inc Borsa (BNGO) Ultime notizie
Bionano outlines $30M–$33M revenue target for 2026 with focus on routine user growth and margin expansion - MSN
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 earnings call transcript - MSN
Bionano Genomics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-03-24 - Seeking Alpha
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript - Insider Monkey
Bionano Genomics Reports 2025 Financial Results, Highlights OGM Adoption and Announces 2026 Revenue Outlook - Minichart
Bionano Genomics earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN
Bionano Genomics 2025 Annual Report Highlights: Optical Genome Mapping, Market Expansion, and Risk Factors 57596054 - Minichart
Bionano Q4 2025 slides: margins surge 47% as cost cuts offset revenue dip - Investing.com Canada
Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Earnings Call Summary | Bionano Genomics(BNGO.US) Q4 2025 Earnings Conference - Moomoo
Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Na - GuruFocus
Bionano Q4 2025 slides: margins surge 47% as cost cuts offset revenue dip By Investing.com - Investing.com South Africa
Bionano Genomics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Bionano Genomics (BNGO) Reports Q4 2025 Earnings, Sets 2026 Reve - GuruFocus
Bionano Genomics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Bionano Genomics (BNGO) Earnings Transcript - The Globe and Mail
Bionano Genomics (BNGO) Sees Promising Growth in Optical Genome Mapping - GuruFocus
Earnings call transcript: Bionano Genomics’ Q4 2025 results show cost cuts, stock surges - Investing.com
Bionano Genomics (BNGO) Reports Q4 Revenue Beat Despite Lower Sa - GuruFocus
Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story - Benzinga
BNGO Projects Revenue Growth for FY26 - GuruFocus
Bionano Genomics shares are trading higher af... - Benzinga
Bionano Genomics 2025 10-K: Revenue $28.5M, EPS $(4.85) - TradingView
Bionano Genomics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Going-concern risk and OGM growth focus at Bionano Genomics (NASDAQ: BNGO) - Stock Titan
BRIEF-Bionano Genomics Q4 Revenue USD 8 Million - TradingView
Bionano Genomics, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2026 - marketscreener.com
[8-K] Bionano Genomics, Inc. Reports Materia... - Stock Titan
Bionano Genomics Surges 21.7% on Strong Technical Signals and Pre-Earnings Optimism – What’s Next for BNGO? - Bitget
United Airlines, AGI And 3 Stocks To Watch Heading Into Monday - Benzinga
Bionano Genomics, Inc. (BNGO) - Minichart
Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Sahm
Bionano Genomics Inc (BNGO) Stock Price, Quote, News & History - Benzinga
Bionano Genomics Inc expected to post a loss of $1.40 a shareEarnings Preview - TradingView
BNGO PE Ratio & Valuation, Is BNGO Overvalued - Intellectia AI
Bionano Genomics, Inc.: Fundamental Analysis and Financial Ratings | | US09075F3055 - marketscreener.com
Chart Watch: Is Bionano Genomics Inc benefiting from interest rate changesWeekly Trade Review & Reliable Momentum Entry Alerts - baoquankhu1.vn
Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting - The Manila Times
Bionano Announces Two-Fold Increase in OGM Studies - GlobeNewswire
Bionano Genomics (BNGO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Quarterly Recap: Is Bionano Genomics Inc being accumulated by smart moneyEarnings Overview Report & Daily Market Momentum Tracking - baoquankhu1.vn
Pharma News: Is Bionano Genomics Inc stock a value trapWeekly Investment Report & Free High Return Stock Watch Alerts - baoquankhu1.vn
Bionano to Report Q4 and 2025 Results on March 23 - National Today
Bionano Genomics to Release 2025 Financial Results and Host Investor Call on March 23, 2026 - geneonline.com
Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 - The Manila Times
Bionano to Report Fourth Quarter and Full Year 2025 - GlobeNewswire
BioNano Genomics (BNGO) Receives a Buy from Maxim Group - The Globe and Mail
Growth Report: Is Bionano Genomics Inc benefiting from interest rate changesJuly 2025 Market Mood & Breakout Confirmation Trade Signals - baoquankhu1.vn
Panic Selling: Is Bionano Genomics Inc backed by strong institutional buying2025 Analyst Calls & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Bear Alert: What Wall Street predicts for Bionano Genomics Inc. stock priceJuly 2025 Selloffs & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Bionano Genomics (BNGO) Advances Optical Genome Mapping at Sympo - GuruFocus
Bionano Genomics Inc Azioni (BNGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):